Ketorolac Tromethamine
Lumbar Spinal Stenosis
University of RochesterPhase 4 / ApprovedDormant
BB
66/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 51/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Lumbar Spinal Stenosis cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE Hadassah Medical Organization | Phase 4 | BB |
FENTANYL University of Rochester | Phase 4 | BB |
Pregabalin University of Rochester | Phase 4 | BB |
Benadryl University of Rochester | Phase 4 | BB |
HYDROMORPHON University of Rochester | Phase 4 | BB |
EVUZAMITIDE University of Tennessee Graduate School of Medicine | Phase 2 | CCC |
Same molecule, other indications
Ketorolac Tromethamine is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →